MBI-HMed BioGene Inc.

TSXV · CA · Healthcare · Diagnostics & Research · medbiogene.com

0.0300CAD0.00%Mkt Cap: 314205 $P/E: Infinity3d ago

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap314.20K $

Enterprise Value451.73K $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-33.86K $

Revenue/Share—

Last Price0.0300 CAD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)Infinity

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-1.36

EPS (TTM)0.00

EPS (Forward)—

52W Range

0.020033% of range0.0500

52W High0.0500 CAD

52W Low0.0200 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE20.75%

ROA-2088.63%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-32.23K $

CapEx (TTM)—

FCF Margin—

FCF Yield-37.60%

Net Debt137.53K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.04

Quick Ratio0.00

Book Value/Sh-0.0183 CAD

Cash/Share0.0000 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateDec 19, 2017

Splits

Last Split1:10

Split DateDec 19, 2017

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.17.26M

Float9.43M

Insiders49.22%

Institutions0.00%

Short Interest

Short % Out.0.00%

Shares Short403

Short (prev mo.)403

Technical

SMA 500.0300 (-0.0%)

SMA 2000.0253 (+18.8%)

Beta1.57

S&P 52W Chg18.16%

Avg Vol (30d)0

Avg Vol (10d)0

Technical Indicators

RSI (14)99.9

MACD0.0001

MACD Signal0.0001

MACD Hist.-0.0000

BB Upper0.0300 CAD

BB Middle0.0300 CAD

BB Lower0.0300 CAD

BB Width0.00%

ATR (14)0.0000 CAD

Vol Ratio (20d)—